Lucid Diagnostics Inc.
LUCD
$1.39
$0.118.59%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 49.68% | 513.84% | 124.44% | 828.57% | 930.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.68% | 513.84% | 124.44% | 828.57% | 930.26% |
| Cost of Revenue | 3.06% | 4.20% | 23.77% | -9.95% | 0.49% |
| Gross Profit | 39.84% | 54.10% | 26.57% | 72.31% | 45.10% |
| SG&A Expenses | 15.37% | 15.45% | -25.06% | -18.14% | -15.19% |
| Depreciation & Amortization | -79.21% | -79.21% | -54.41% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.02% | 3.62% | -20.12% | -17.19% | -17.59% |
| Operating Income | -5.09% | 3.38% | 24.62% | 23.52% | 22.60% |
| Income Before Tax | 12.93% | 3.30% | 34.68% | 27.45% | 0.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.93% | 3.30% | 34.68% | 27.45% | 0.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.93% | 3.30% | 34.68% | 27.45% | 0.98% |
| EBIT | -5.09% | 3.38% | 24.62% | 23.52% | 22.60% |
| EBITDA | -9.29% | -0.11% | 24.91% | 24.62% | 23.80% |
| EPS Basic | 27.64% | 16.10% | -1.44% | 35.96% | 13.88% |
| Normalized Basic EPS | 13.51% | 17.55% | 36.77% | 32.77% | 32.36% |
| EPS Diluted | 27.64% | 16.10% | -1.44% | 35.96% | 13.88% |
| Normalized Diluted EPS | 13.51% | 17.55% | 36.77% | 32.77% | 32.36% |
| Average Basic Shares Outstanding | 20.33% | 15.25% | 9.87% | 13.27% | 14.99% |
| Average Diluted Shares Outstanding | 20.33% | 15.25% | 9.87% | 13.27% | 14.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
